• Study on the Safety and Effectiveness of Eltanexor for Patients with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

    Recruiting

    2 1 1
    Investigated drugs:
    Italy
  • Study on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment

    Recruiting

    2 1 1 1
    Investigated diseases:
    France Italy Spain
  • Study on Enfortumab Vedotin for Patients with Advanced Neuroendocrine Carcinoma Not Responding to or Ineligible for Platinum Chemotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients 55+ with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated diseases:
    Finland France Sweden
  • Study on Bevacizumab and Dexamethasone for Treating Brain Radiation Damage in Patients with High-Grade Glioma or Brain Metastases

    Recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands
  • Study of atropine eye drops (0.

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Spain
  • Study on Low-Dose Gadolinium for Breast Cancer MRI in Patients Using Gadoteric Acid

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated diseases:
    Austria Belgium France Germany Greece Hungary +4
  • Study on the Effectiveness and Safety of Mitomycin C with Electric Current for Treating Non-Muscle Invasive Bladder Cancer in Patients, Compared to Standard Immunotherapy

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Effects of Dexamethasone in Adults with Acute Respiratory Failure Due to Infections, Including COVID-19

    Recruiting

    3 1 1 1
    Investigated diseases:
    Spain

powered by